Filing Flows › Harmony Biosciences Holdings (HRMY) › Capital expenditures
Harmony Biosciences Holdings (HRMY) capital expenditures by quarter
Harmony Biosciences Holdings' capital expenditures were $107K in Q4 2025 (fourth quarter 2025), +51% from Q3 2025. Over the last 4 quarters it ranged from $4K (Q2 2025) to $128K (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $107K | +51% | — |
| Q3 2025 | $71K | 18× | — |
| Q2 2025 | $4K | -97% | — |
| Q1 2025 | $128K | — | — |
Q4 2025 at a glance
Harmony Biosciences Holdings, Q4 2025: revenue $244M (+21% year over year), operating margin 15.8%, net earnings $22.5M, operating cash flow $126M. The chart follows the revenue to costs, profit and cash.
Questions
What is Harmony Biosciences Holdings' capital expenditures?
Harmony Biosciences Holdings' capital expenditures were $107K in Q4 2025 (fourth quarter 2025), +51% from Q3 2025.
How has Harmony Biosciences Holdings' capital expenditures changed?
Over the last 4 quarters it ranged from $4K (Q2 2025) to $128K (Q1 2025).
Q4 2025 results → · How Harmony Biosciences Holdings makes money →